Copaxone (Glatiramer Acetate)

Drug Name: Copaxone (Glatiramer Acetate)
Company: Teva Pharmaceutical Industries
Location: Israel
Website: http://www.tevapharm.com
Drug Type: Protein Biologic
Conditions: ALS
Mechanism Type: Immunomodulation
Mechanism: Copaxone is a synthetic protein composed of four amino acids found in myelin basic protein (MBP). The drug simulates MBP, and prevents damage to myelin caused by T-cells.
U.S. Status for ALS: Discontinued

References:
[1] Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS). ClinicalTrials.gov, 29 Aug 2013. Accessed 11 Mar 2016 from https://clinicaltrials.gov/ct2/show/NCT00326625.
[2] Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double- blind, randomized, multicentre, placebo-controlled trial. Meininger, V et al. Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):378-83.

Last updated March 11th, 2016

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail